microRNA-221 restricts human cytomegalovirus replication via promoting type I IFN production by targeting SOCS1/NF-κB...

Area of Science:

• Virology
• Molecular Biology
• Immunology

Background:

• Human Cytomegalovirus (HCMV) is a prevalent pathogen causing severe outcomes in immunocompromised individuals and newborns.
• Understanding host-pathogen interactions is crucial for developing antiviral strategies.

Purpose of the Study:

• To investigate the role of microRNA-221 (miR-221) in neural precursor cells (NPCs) during HCMV infection.
• To elucidate the molecular mechanisms by which miR-221 affects HCMV replication and host antiviral responses.

Main Methods:

• Quantification of miR-221 expression in HCMV-infected NPCs.
• Luciferase reporter assays to confirm direct targeting of SOCS1 by miR-221.
• Western blot and qRT-PCR to assess protein and mRNA levels of SOCS1.
• Assessment of HCMV replication, type I interferon (IFN) and interferon stimulating genes (ISGs) production, and NF-κB activation.
• In vivo studies using miR-221 agomir in a mouse model of MCMV infection.

Main Results:

• HCMV infection significantly upregulated miR-221 expression in NPCs.
• miR-221 was found to directly target and suppress the expression of Suppressor of Cytokine Signaling 1 (SOCS1).
• Overexpression of miR-221 inhibited HCMV replication by enhancing type I IFN and ISG production, an effect abrogated by SOCS1 reintroduction.
• miR-221 promoted NF-κB activation by suppressing SOCS1.
• In vivo administration of miR-221 agomir reduced MCMV-induced tissue injury via enhanced type I IFN antiviral activity.

Conclusions:

• miR-221 functions as an intrinsic antiviral factor against HCMV by targeting SOCS1, promoting type I IFN responses, and activating NF-κB.
• miR-221 holds potential as a therapeutic target for developing novel anti-HCMV treatments.